Search details
1.
Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma.
Proc Natl Acad Sci U S A
; 113(42): E6409-E6417, 2016 10 18.
Article
in English
| MEDLINE | ID: mdl-27702896
2.
Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancer.
Oncotarget
; 10(47): 4822-4839, 2019 Aug 06.
Article
in English
| MEDLINE | ID: mdl-31448050
3.
Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer.
Cancer Res
; 77(2): 566-578, 2017 01 15.
Article
in English
| MEDLINE | ID: mdl-27872098
4.
Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor.
Mol Cancer Ther
; 16(6): 1041-1053, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28292938
5.
SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells.
Oncotarget
; 6(35): 37410-25, 2015 Nov 10.
Article
in English
| MEDLINE | ID: mdl-26485762
6.
The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitors.
Pigment Cell Melanoma Res
; 28(4): 417-30, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25854919
7.
mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation.
Cancer Cell
; 27(1): 41-56, 2015 Jan 12.
Article
in English
| MEDLINE | ID: mdl-25584893
8.
PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets.
Cancer Res
; 75(7): 1399-412, 2015 Apr 01.
Article
in English
| MEDLINE | ID: mdl-25712345
9.
Salmonella pathogenicity island-2 and anticancer activity in mice.
Cancer Gene Ther
; 9(10): 813-8, 2002 Oct.
Article
in English
| MEDLINE | ID: mdl-12224021
10.
Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cells.
Mol Cancer Res
; 12(8): 1140-55, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24829397
11.
MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL.
Pigment Cell Melanoma Res
; 26(4): 527-41, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23617806
12.
Genotype-selective combination therapies for melanoma identified by high-throughput drug screening.
Cancer Discov
; 3(1): 52-67, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-23239741
13.
ß-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas.
Cancer Cell
; 20(6): 741-54, 2011 Dec 13.
Article
in English
| MEDLINE | ID: mdl-22172720
Results
1 -
13
de 13
1
Next >
>>